We can do something about heart failure. Ultrasound is making a real difference.
In early detection. Before the onset of severe clinical symptoms, ultrasound helps you to assess and quantify intraventricular dyssynchrony and dyssynchronous wall motion
In CRT (cardiac resynchronization therapy) and ICD (implantable cardioverter defibrillator) therapy.
Ultrasound helps you:
- Identify patients most likely to benefit
- Optimize pacing parameters
- Determine potential placement locations
- Monitor post-placement cardiac function
Helping you turn the tide
Now you can do even more for your patients. Cardiologists have guided the development of Philips iE33, our comprehensive cardiac ultrasound solution - and it shows.
The iE33 now helps you evaluate patients in every stage of heart failure more quickly and accurately.
Revolutionary 2D image quality, unparalleled 3D technology, and a powerful feature set of advanced quantification tools set this system apart from the rest.
PureWave technology for 2D
At the heart of PureWave is pure, uniform piezocrystal - the biggest breakthrough in transducer material in forty years. Significantly superior acoustic properties – as compared to traditional ceramic PZT (lead zirconate and titanate polycrystalline compound) – and exclusively ours.
The result?
Image quality improvement that’s instantly apparent - greater sensitivity accounts for the remarkable improvement
The same great performance on every patient – due to an extremely broad frequency range
Ideal for patients that are “technically difficult to image” – the broader bandwidth provides better penetration and greater harmonic imaging sensitivity
Award-winning technology – rated in the “Top 100” by R&D Magazine2
Live 3D Echo makes a difference
Philips xMATRIX technology is the 3D core of the iE33 system, supporting Live 3D Echo for transthoracic and transesophageal application. The 3D beating heart is displayed in real time providing you with views not available in 2D, and allowing full assessment of cardiac function, morphology, and structural relationships.
- Comprehensive interrogation and quantification of 3D data sets
- Greater confidence in decisions to repair vs. replace
- Increased visualization during interventional procedures
- Images reflect actual heart size – with no geometrical assumptions.
QLAB – a powerful quantification tool
QLAB has been validated as an accurate, efficacious aid in assessing cardiac function. This advanced software:
Individually, these 3 features stand on their own, but their combination can offer you even more clinical value.
2D and 3D plus QLAB:
Advanced echo technology for CRT and ICD therapy
This advanced feature set makes the iE33 the logical choice for comprehensive assessment, planning, and post-procedural follow-up
- Strain Quantification – acknowledged as a vital functionality parameter – provides a way to analyze tissue motion (velocities) using 2D images to get specific segmental timing data
- 3D Synchronicity Indices – provide synchronicity indicators
- Values are assigned to the synchronicity of all segments
- 3D looks at changes over time, helping you evaluate how segments change as they reach minimum volume
- QLAB calculates whether segments reach minimum volume together - or not. Minimum volumes achieved at different times indicate dyssynchrony.
The iE33 combines exceptional image quality with essential quantification features in one powerful triage tool. With it, you can detect and assess the extent of heart failure in its earliest stages - at the point of care. You can also identify with increased confidence patients likely to benefit from CRT and ICD placement. With added information, device placement can be more effectively planned and post-procedural evaluation more easily conducted.
1. ACC/AHA 2005 Update to the Guidelines for the Evaluation and Management of Chronic Heart Failure
2. R&D Magazine, “Oscars of Invention” Annual Awards Issue; September, 2005
3. Improved Semi-automated Quantification of Left Ventricular Volumes and Ejection Fraction Using 3-Dimensional Echocardiography… Comparison with Magnetic Resonance Imaging J AM Soc Echocardiography 2005; 18: 779-788; Real-Time Three-Dimensional Echocardiography A Novel Technique to Quantify Global Left Ventricular Mechanical Dyssonchrony Circulation. 2005; 112: 992-1000; Assessment of the Effect of Cardiac Resynchronization Therapy on Intraventricular Mechanical Synchronicity by Regional Volumetric Change Am J Cardio 2005; 95: 126-129